DBV Technologies SA banner

DBV Technologies SA
PAR:DBV

Watchlist Manager
DBV Technologies SA Logo
DBV Technologies SA
PAR:DBV
Watchlist
Price: 3.534 EUR -2.91%
Market Cap: €983.7m

DBV Technologies SA
Intangible Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

DBV Technologies SA
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
DBV Technologies SA
PAR:DBV
Intangible Assets
$22k
CAGR 3-Years
30%
CAGR 5-Years
-12%
CAGR 10-Years
-14%
Valneva SE
PAR:VLA
Intangible Assets
€22.3m
CAGR 3-Years
-8%
CAGR 5-Years
-9%
CAGR 10-Years
-14%
G
Genfit SA
PAR:GNFT
Intangible Assets
€4.2m
CAGR 3-Years
-54%
CAGR 5-Years
39%
CAGR 10-Years
21%
Inventiva SA
PAR:IVA
Intangible Assets
€85k
CAGR 3-Years
-48%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Cellectis SA
PAR:ALCLS
Intangible Assets
$535k
CAGR 3-Years
-9%
CAGR 5-Years
-20%
CAGR 10-Years
-6%
Abivax SA
PAR:ABVX
Intangible Assets
€6.6m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

DBV Technologies SA
Glance View

Market Cap
983.7m EUR
Industry
Biotechnology

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The company is headquartered in Montrouge, Ile-De-France. The company went IPO on 2012-03-29. The firm's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. The company dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The firm's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The firm operates one subsidiary DBV Technologies Inc. in the United States.

DBV Intrinsic Value
1.224 EUR
Overvaluation 65%
Intrinsic Value
Price €3.534

See Also

What is DBV Technologies SA's Intangible Assets?
Intangible Assets
22k USD

Based on the financial report for Dec 31, 2025, DBV Technologies SA's Intangible Assets amounts to 22k USD.

What is DBV Technologies SA's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
-14%

Over the last year, the Intangible Assets growth was -45%. The average annual Intangible Assets growth rates for DBV Technologies SA have been 30% over the past three years , -12% over the past five years , and -14% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett